Sorrento Therapeutics Inc. (SRNE)

2.34
0.13 5.30
NASDAQ : Health Technology
Prev Close 2.47
Open 2.47
Day Low/High 2.26 / 2.47
52 Wk Low/High 2.45 / 10.65
Volume 1.09M
Avg Volume 1.60M
Exchange NASDAQ
Shares Outstanding 122.27M
Market Cap 306.91M
EPS 0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACC, HNI, OAK, SIM Downgrades: GFED, GROW, SRNE, STCN Initiations: CADE Read on to get TheStreet Quant Ratings' detailed report:

SRNE Crosses Below Key Moving Average Level

SRNE Crosses Below Key Moving Average Level

In trading on Tuesday, shares of Sorrento Therapeutics Inc crossed below their 200 day moving average of $5.66, changing hands as low as $5.40 per share. Sorrento Therapeutics Inc shares are currently trading down about 9% on the day.

Interesting SRNE Put And Call Options For July 20th

Interesting SRNE Put And Call Options For July 20th

Investors in Sorrento Therapeutics Inc saw new options begin trading this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new July 20th contracts and identified one put and one call contract of particular interest.

First Week Of August 17th Options Trading For Sorrento Therapeutics (SRNE)

First Week Of August 17th Options Trading For Sorrento Therapeutics (SRNE)

Investors in Sorrento Therapeutics Inc saw new options begin trading this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new August 17th contracts and identified one put and one call contract of particular interest.

First Week Of December 21st Options Trading For Sorrento Therapeutics (SRNE)

Investors in Sorrento Therapeutics Inc saw new options become available this week, for the December 21st expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round

Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round

Jim Cramer highlights Spotify, Alkermes, Sorrento Therapeutics, Thermo Fisher Scientific, Kohlberg Kravis Roberts, and more.

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Washington receded and earnings came to the fore, but we're still seeing insane values and some surprises, says Jim Cramer.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BDL, SRNE Downgrades: BIG, BSET, GTN.A, INS, ISRL, NICK, SNDX Initiations: PLYA Read on to get TheStreet Quant Ratings' detailed report:

There's Plenty of Positive Action But It's a Little Overheated

There's Plenty of Positive Action But It's a Little Overheated

I'll be watching for entry points to develop this afternoon.

DowDuPont, Sorrento Therapuetics, Lockheed Martin: 'Mad Money' Lightning Round

DowDuPont, Sorrento Therapuetics, Lockheed Martin: 'Mad Money' Lightning Round

Jim Cramer highlights DowDuPont, Sorrento Therapuetics, Lockheed Martin, ZAGG, Worldpay, Pattern Energy, AMC Networks.

The Sky Is Not Falling: Cramer's 'Mad Money' Recap (Tuesday 3/6/18)

The Sky Is Not Falling: Cramer's 'Mad Money' Recap (Tuesday 3/6/18)

Trade wars, tariffs, Gary Cohn's resignation... yes, all shocking. But investors need to buy what's working, says Jim Cramer.

Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy For Liver Metastases Demonstrates Therapeutic Activity In Stage IV Pancreas Cancer In A Phase 1b HITM-SURE Trial (NCT02850536)

Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy For Liver Metastases Demonstrates Therapeutic Activity In Stage IV Pancreas Cancer In A Phase 1b HITM-SURE Trial (NCT02850536)

One subject with stage IV pancreas cancer has no viable liver metastases by PET scan 11 months after treatment

Insiders Seeing Green With SRNE At New 52-Week High

Insiders Seeing Green With SRNE At New 52-Week High

In trading on Thursday, shares of Sorrento Therapeutics Inc touched a new 52-week high of $10.65/share. That's a 610.00% rise, or $9.15 per share from the 52-week low of $1.50 set back on 08/24/2017.

I'm Not Feeling There's Support for a Bounce Now

I'm Not Feeling There's Support for a Bounce Now

I'm focused on managing positions and am doing very little new buying at this point.

Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval For Non-Opioid ZTlido™ (lidocaine Topical System) 1.8% For PHN Pain

Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval For Non-Opioid ZTlido™ (lidocaine Topical System) 1.8% For PHN Pain

ZTlido™ Uses Novel Technology Demonstrating 12-Hour Wear for Efficient Lidocaine Delivery, Even During Exercise

First Week of SRNE April 20th Options Trading

First Week of SRNE April 20th Options Trading

Investors in Sorrento Therapeutics Inc saw new options become available this week, for the April 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SRNE options chain for the new April 20th contracts and identified one put and one call contract of particular interest.

With an Eye on Biotech, Here's Today's Trading Thesis

With an Eye on Biotech, Here's Today's Trading Thesis

It is important to note that watching for a reversal is much different than being short.

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Here's what you need to know now for Wednesday, Feb. 14.

Biotech Heats Up as Fear of Missing Out Returns

Biotech Heats Up as Fear of Missing Out Returns

It's hard to believe the bounce will continue to run in V-shaped fashion.

Seeing Good Action in Several Stocks, Buying More MJ, Gold

Seeing Good Action in Several Stocks, Buying More MJ, Gold

It is a very different market environment now which can be very rewarding depending on your style.

TheStreet Quant Rating: D (Sell)